In October, LELAIVA has compiled information related to assisted reproductive technologies for you to refer to this month.Compliance main lineFor the industry, compliance is not a burden, but rather the foundation of trust. This article outlines three key principles that must be remembered, both for institutions to use in their self-inspections, and for patients to be aware of.

1. Red line 1: Medical insurance funds – must not be touched.

This month, we have been continuously working to combat fraud in assisted reproduction services. Practices such as creating false treatment plans, swapping codes between different treatments, and impersonating doctors have been targeted for regulation. For patients, it’s important to choose qualified institutions, carefully check the settlement details, and not lend out medical insurance cards. This not only protects the patients themselves but also safeguards the entire healthcare system.

II. Red Line 2: Ad compliance is essential; any false claims are unacceptable.

Advertisements related to reproductive services are strictly prohibited from making any claims about efficacy, suggesting gender selection, or using patients as endorsements for such advertisements. This month, we once again emphasize that any statements claiming “guaranteed success” or suggesting gender selection are illegal. Patients, please remember: don’t trust any advertisements that promise certain results, and avoid anything that suggests a specific gender.

III. Red Line Three: Personal Data – Must Not Be Leaked

Assisted reproduction involves highly sensitive information. Institutions must implement measures such as minimizing the use of this information, storing it in encrypted form, and sharing it only when necessary. Patients should also be aware of the whereabouts of their personal information. Privacy is the cornerstone of industry trust.

IV. The Positive Aspects of Policy Measures This Month

Beyond compliance, there is also warmth to be felt: medical insurance has evolved from covering all 31 provinces to having a unified payment range. Regional markets are becoming more active, and five key programs are helping to reduce costs for patients. Regulation and benefits for the people are actually two sides of the same coin.

V. Compliance Outlook for November

• As Double Eleven approaches, be cautious of attempts to use "promotional sales" as a means to redirect users to medical services.
• World Prematurity Day: Pay attention to compliance throughout the entire management process.
• Health tips for the start of winter season. Continue to avoid being misled by those所谓的“神奇怀孕秘方”。

Lelaiwa小结

The keyword for October is “guardance”. Only by maintaining control over funds, advertising practices, and privacy can the industry move forward steadily and achieve long-term success. LELAWA is committed to being a partner who adheres to regulations, as well as serving as a “lightning rod” for patients.

Compliance guidelinesThis article is based on a review of relevant regulations and regulatory developments. Specific enforcement actions shall be subject to the decisions of the relevant regulatory authorities.